186
Views
27
CrossRef citations to date
0
Altmetric
Original Article

Studies on nonionic surfactant bilayer vesicles of ciclopirox olamine

, &
Pages 946-953 | Received 07 Sep 2009, Accepted 22 Dec 2009, Published online: 02 Mar 2010

References

  • Ellis D. Management of cutaneous fungal infections. Mycology online, http://www.mycology.adelaide.edu.au/downloads/DermMan.pdf [accessed January 6, 2009].
  • Majdeline EMR, Yogeshvar NK. (2006). New developments in topical antifungal therapy. Am J Drug Deliv, 4(4):231–47.
  • De Logu A, Fadda AM, Anchisi C, Maccioni AM, Sinico C, Schivo ML, . (1997). Effects of activity of miconazole and ketoconazole in phospholipids formulations. J Antimicrob Chemother, 40:889–93.
  • Qi XR, Liu MH, Liu HY, Maitani Y, Nagai T. (2003). Topical econazole delivery using liposomal gel. STP Pharm Sci, 13(4):241–5.
  • Kassem MAA, Esmat S, Bendas ER, El-Komy MHM. (2006). Efficacy of topical griseofulvin in treatment of tinea corporis. Mycoses, 49(3):232–5.
  • Baillie AJ, Florence AT, Hume LR, Muirhead GT, Rogerson A. (1985). The preparation and properties of niosomes-non-ionic surfactant vesicles. J Pharm Pharmacol, 37:863–8.
  • Uchegbu IF, Vyas SP. (1998). Non ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm, 172:33–70.
  • Shahiwala A, Misra A. (2002). Studies in topical application of niosomally entrapped nimesulide. J Pharm Pharm Sci, 5(3):220–5.
  • Manosroi A, Jantrawuta P, Manosroi J. (2008). Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium. Int J Pharm, 360(1–2):156–63.
  • Vyas SP, Singh RP, Jain S, Mishra V, Mahor S, Singh P, . (2005). Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B. Int J Pharm, 296:80–6.
  • Paolino D, Cosco D, Muzzalupo R, Trapasso E, Picci N, Fresta M. (2008). Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer. Int J Pharm, 353:233–42.
  • Suwakul W, Ongpipattanakul B, Vardhanabhuti N. (2006). Preparation and characterization of propylthiouracil niosomes. J Liposome Res, 16:391–401.
  • Balasubramaniam A, Kumar VA, Pillai KS. (2002). Formulation and in vivo evaluation of niosome-encapsulated daunorubicin hydrochloride. Drug Dev Ind Pharm, 28:1181–93.
  • Barakat HS, Darwish IA, El-Khordagui LK, Khalafallah NM. (2009). Development of naftifine hydrochloride alcohol-free niosome gel. Drug Dev Ind Pharm, 35(5):631–7.
  • Manconi M, Sinico C, Valenti D, Lai F, Fadda AM. (2006). Niosomes as carriers for tretinoin III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. Int J Pharm, 311:11–9.
  • Carafa M, Marianecci C, Lucania G, Marchei E, Santucci E. (2004). New vesicular ampicillin loaded delivery systems for topical application: Characterization, in vitro permeation experiments and antimicrobial activity. J Control Release, 95:67–74.
  • Patravale VB, Mandawgade SD. (2008). Novel cosmetic delivery systems: An application update. Int J Cosmet Sci, 30:19–33.
  • Manconi M, Valenti D, Sinico C, Lai F, Loy G, Fadda AM. (2003). Niosomes as carriers for tretinoin II. Influence of vesicular incorporation on tretinoin photostability. Int J Pharm, 260:261–72.
  • Tarawneh RT, Hamdan II, Bani-Jaber A, Darwish RM. (2005). Physicochemical studies on ciclopirox olamine complexes with divalent metal ions. Int J Pharm, 1(2):179–87.
  • Sigle HC, Thewes S, Niewerth M, Korting HC, Korting MS, Hube B. (2005). Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans. J Antimicrob Chemother, 55:663–73.
  • Gupta AK, Skinner AR. (2003). Ciclopirox for the treatment of superficial fungal infections: A review. Int J Dermatol, 42:3–9.
  • Hao Y, Zhao F, Li N, Yang Y, Li K. (2002). Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm, 244:73–80.
  • Du S, Deng Y. (2006). Studies on the encapsulation of oxymatrine into liposomes by ethanol injection and pH gradient method. Drug Dev Ind Pharm, 32(7):791–7.
  • Fan M, Xu S, Xia S. (2008). Preparation of salidroside nano-liposomes by ethanol injection method and in vitro release study. Eur Food Res Technol, 227:167–74.
  • Walash MI, Rizk MS, Eid MI, Fathy MS. (2006). Spectrofluorimetric determination of ciclopirox olamine via ternary complex with Tb (III) and EDTA. Acta Pharm, 56:431–40.
  • Heurtault B, Saulnier P, Pech B, Proust JE, Benoit JP. (2003). Physico-chemical stability of colloidal lipid particles. Biomaterials, 24:4283–300.
  • Fouda MMG, Knittel D, Hipler UC, Elsner P, Schollmeyer E. (2006). Antimycotic influence of β-cyclodextrin complexes—In vitro measurements using laser nephelometry in microtiter plates. Int J Pharm, 311(1–2):113–21.
  • Plessis J, Ramchandran C, Weiner N, Muller DG. (1996). The influence of lipid composition and lamellarity of liposomes on the physical stability of liposomes upon storage. Int J Pharm, 127:273–8.
  • Sarpotdar PP, Zatz JL. (1986). Percutaneous absorption enhancement by nonionic surfactants. Drug Dev Ind Pharm, 12:1625–47.
  • Hofland HEJ, Junginger HE, Bouwstra JA. (1994). Estradiol permeation from non-ionic surfactant vesicles through human skin. Pharm Res, 11(5):659–64.
  • Hofland HEJ, Bouwstra JA, Spies F, Bodde HE, Junginger HE. (1995). Interactions between non ionic surfactant and human skin in-vitro. Br J Dermatol, 132(6):853–66.
  • Verma DD, Verma S, Blume G, Fahr A. (2003). Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm, 258:141–51.
  • Nasseri B. (2005). Effect of cholesterol and temperature on the elastic properties of niosomal membranes. Int J Pharm, 300:95–101.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.